Evidence map›Paper›PMID 42223277›Full record

ArticleJournal of paediatrics and child health2026

Changes in Hospital Care for Children With IBD Across Australia From 2014 to 2022.

Laura Rishanghan, David Skvarc, Stefan Moller, Ramesh Nataraja, Scott Nightingale, Christopher Burgess, Shoma Dutt, George Alex, Helen Jurgens, Ajay Sharma and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of paediatrics and child health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laura RishanghanDepartment of Gastroenterology, Monash Children's Hospital, Monash Health, Melbourne, Victoria, Australia.
David SkvarcSchool of Psychology, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
Stefan MollerIndependent Researcher, Melbourne, Australia.ORCID https://orcid.org/0000-0001-6710-3854
Ramesh NatarajaDepartment of Paediatrics and Surgery, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Scott NightingaleJohn Hunter Children's Hospital, Paediatric Gastroenterology, Newcastle, Australia.
Christopher BurgessQueensland Children's Hospital, Department of Gastroenterology, Hepatology and Liver Transplant, Brisbane, Australia.
Shoma DuttChildren's Hospital Westmead, Department of Gastroenterology, Sydney, Australia.
George AlexDepartment of Gastroenterology and Clinical Nutrition, The Royal Children's Hospital, Melbourne, Australia.
Helen JurgensWomen's & Children's Hospital, Paediatric Gastroenterology, Adelaide, Australia.
Ajay SharmaFiona Stanley Hospital, Paediatric Gastroenterology, Perth, Australia.
Paul HammondWomen's & Children's Hospital, Paediatric Gastroenterology, Adelaide, Australia.
Cheryl FooJoondalup Health Campus, Perth, Australia.
Leanne RavenCrohn's & Colitis Australia, Melbourne, Australia.
Antonina Mikocka-WalusSchool of Psychology, Deakin University, Geelong, Australia.
Wayne MassugerCrohn's & Colitis Australia, Melbourne, Australia.ORCID https://orcid.org/0000-0002-1887-4107
Edward GilesCentre for Innate Immunity and Infectious Disease, Hudson Institute for Medical Research, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-3295-1575

Funding

Department of Health and Aged Care, Australian Government
6 · The paper itself

Abstract

backgroundInflammatory bowel disease is a chronic, lifelong gastrointestinal disorder, with 8%-10% of patients diagnosed < 18 years old. Over the last decade, there has been a global increase in paediatric IBD (pIBD) incidence and changes in therapeutic approaches. Our study aimed to assess the changes in hospital care for young people with IBD from 2014 to 2022.

methodsComplete national pIBD data on admissions was collected through the Australian Institute of Health and Welfare (AIHW). Hospitals nationally were invited to participate in a clinical audit of inpatient overnight admissions for 2021. Data was compared to a previous study from 2014.

resultsThere were 813 overnight pIBD admissions in 2021, compared to 590 in 2014. Eight public hospitals participated, with 186 admissions, capturing 23% of all 2021 pIBD admissions. UC admission rates doubled; however, surgical admissions reduced (16% in 2014 to 5% in 2021, p < 0.05). CD and surgical admissions remained stable. There was reduced corticosteroid use, and 56 patients had off-label medication use. Sixty-five percent of patients had active disease at the last clinic review. There was a trend towards shorter admissions, and re-admission rates were similar to previous global data. Despite psychological co-morbidity in 28% of cases, psychologists were not part of the team at any site.

conclusionThis study showed a significant increase in UC admissions in Australia over the last decade. Medication changes were in line with global trends, and multi-disciplinary care remained inadequate despite national standards. This data provides evidence for planning and resourcing pIBD care nationally and worldwide.

Indexed as

HospitalizationInflammatory Bowel DiseasesAdolescentAustraliaChildChild, PreschoolFemaleHumansMaleadmissionhospitalnational standardspaediatric

Identifiers

PMID42223277
PMCPMC13378197

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.